Legal Representation
Attorney
Monica Riva Talley
USPTO Deadlines
Next Deadline
60 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
October 01, 2025
Extension Available
Until October 01, 2025
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 11, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 10, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 10, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 10, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 1, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 6, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 6, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 17, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 1, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 22, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 22, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 22, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 23, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 23, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 23, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 12, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 15, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 29, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Nov 29, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Nov 29, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Sep 23, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 30, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 4, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products, namely, multifunctional molecules that promote recruitment of antibodies to disease cells or organisms, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, cancers, infectious diseases, and neurological disorders
Class 042
Discovery, research, development, engineering, and testing of pharmaceuticals and substances, namely, functional molecules that promote binding to immune cells and disease cells, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
Classification
International Classes
005
042